Market Signal Briefing

Bitcoin rebounded on Friday afternoon after setting an early intraday low below $104,000.

CryptocurrencyTickerPriceBitcoin(CRYPTO: BTC)$106,795.15Ethereum(CRYPTO: ETH)$3,837.38Solana(CRYPTO: SOL)$183.59XRP(CRYPTO: XRP)$2.30Dogecoin(CRYPTO: DOGE)$0.1850Shiba Inu(CRYPTO: SHIB)$0.059750Notable Statistics:

Coinglass data shows 255,556 traders were liquidated in the past 24 hours for $985.30 million.        
In the past 24 hours, top losers include Aave (CRYPTO: AAVE), Aster (CRYPTO: ASTER) and Monero (CRYPTO: XMR).
Notable Developments:

Is Bitcoin At $106,000 ‘Cheap’? Here’s How You Can Tell
Peter Schiff Says Bitcoin, Ethereum Crash Is ‘Imminent’—But How Much Worse Can It Get?
Ripple Labs Is Leading A $1 Billion Fundraise To Establish XRP-Centered Treasury: Report
Bitfarms Stock Falls As Convertible Notes Swell To $500 Million
Anthony Scaramucci Was ‘Willing’ To Risk His Business For Bitcoin During The 2022 Crypto Winter
Trader Notes: MuroCrypto noted Bitcoin closing above $108,500 would signal a bullish setup, while staying below keeps the outlook bearish.

Current conditions, however, suggest that the bullish scenario remains possible.

Rekt Capital observed that Bitcoin has been oscillating within its macro range this month. The market experienced a fake breakout above the range high, followed by a fake breakdown below the range low, reflecting ongoing indecision.

Castillo Trading highlighted that Bitcoin's weekly chart remains fairly bullish, adding that it would be surprising if the current move marks a market top.

Crypto Tony suggested a long position could be considered if the $107,800 resistance zone flips into support but cautioned that it could also be a bearish retest, emphasizing the need for patience.

Read Next: 

Bitcoin Plunges To $105,000: Is This A Black Friday In The Making?
Image: shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

TL;DR

Tether launched its open-source Wallet Development Kit (WDK), a modular toolkit that enables the creation of secure, self-custodial, and interoperable wallets.
The WDK supports Bitcoin, Lightning, Ethereum, Arbitrum, Polygon, Solana, TON, and other networks, integrating DeFi functions, payments, lending, swaps, and cross-chain transfers.
The kit allows both humans and AI agents to manage funds independently, boosting global adoption of stablecoins and Bitcoin.

Tether has open-sourced its Wallet Development Kit (WDK), a modular toolkit that allows developers to build secure, self-custodial wallets across multiple blockchains.

WDK Advantages
The initiative aims to empower both human users and autonomous machines or AI agents to create, deploy, and use wallets independently, without relying on centralized providers. The WDK is fully open-source and ecosystem-agnostic, enabling auditing, contributions, and flexible, secure development of custom solutions.

The kit supports Bitcoin, Lightning Network, Ethereum, Arbitrum, Polygon, Solana, TON, and other EVM and non-EVM networks. It enables integration of decentralized finance (DeFi) functions, payments, lending, swaps, cross-chain transfers, real-time balance updates, transaction tracking, and customizable user interfaces.

It is designed to run on any device, from mobile and desktop applications to embedded systems, IoT devices, and autonomous environments, ensuring compatibility with smartphones, trading bots, smart appliances, and more complex systems.

Tether’s AI Vision: Building the Future
Tether is increasingly focusing on artificial intelligence. Its open-source runtime, Tether AI, allows AI agents to send and receive payments in Bitcoin and USDT. Paolo Ardoino, the company’s CEO, anticipates that every AI agent will have its own wallet within the next 15 years, with the number of transacting agents potentially reaching one trillion. The goal is to create an open and resilient financial infrastructure where humans and machines have direct control over their funds, promoting the adoption of stablecoins and Bitcoin as means of payment and value storage.

The WDK incorporates USDT0 technology to ensure efficient liquidity and seamless cross-chain bridging, and it already serves as the foundation for projects like Rumble Wallet and Tether’s upcoming self-custodial wallet. End users benefit from an intuitive experience that simplifies complex crypto management, while developers gain a modular, scalable architecture for future innovation.

Tether continues to strengthen its financial infrastructure, promoting economic sovereignty and independence from centralized systems. Its WDK enables individuals, institutions, and even nations to create independent, secure, multi-chain wallets, expanding cryptocurrency adoption worldwide

By Reuters

October 17, 20255:56 PM UTCUpdated ago

Elon Musk attends the opening ceremony of the new Tesla Gigafactory for electric cars in Gruenheide, Germany, March 22, 2022. To match Special Report TESLA-PRIVACY/CAMERAS Patrick Pleul/Pool via REUTERS/File Photo Purchase Licensing Rights, opens new tab

CompaniesOct 17 (Reuters) - Proxy advisory firm Institutional Shareholder Services (ISS) on Friday urged Tesla shareholders to vote against CEO Elon Musk's proposed $1 trillion performance award, citing concerns over excessive compensation and governance risks.

Tesla did not immediately respond to a request for comment.

Sign up here.

Last month, Tesla's board proposed a $1 trillion compensation plan for Musk in what it described as the largest corporate pay package in history, setting ambitious performance targets and aiming to address his push for greater control over the company.

The vote on Musk's pay package is scheduled for early November.

Reporting by Akash Sriram in Bengaluru; Editing by Alan Barona

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Image source: Getty Images

On October 8, 2025, Sheets Smith Investment Management disclosed a new position in J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF (JEPQ 0.56%), acquiring 83,771 shares in an estimated $4.56 million trade.

What happenedAccording to a filing with the Securities and Exchange Commission dated October 8, 2025, Sheets Smith Investment Management initiated a new position in J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF (JEPQ 0.56%). The fund reported holding 83,771 shares, valued at $4.56 million. This marks the fund’s first reported ownership of the ETF.

What else to knowThis new position now represents 4.0% of Sheets Smith Investment Management’s reportable assets under management.

Top holdings after the filing:

VCSH: $8.05 million (7.1% of AUM)JEPQ: $4.56 million (4.0% of AUM)VCIT: $3.26 million (2.9% of AUM)CRS: $2.88 million (2.5% of AUM)NVDA: $2.84 million (2.5% of AUM)As of October 7, 2025, shares were priced at $57.32, up 6.0% over the past year and outperforming the S&P 500 by 0.9 percentage points

JEPQ’s indicated dividend yield is 10.4% as of October 8, 2025; the fund is 1.5% below its 52-week high as of October 7, 2025

Sheets Smith Investment Management reported $113.90 million in 13F assets across 71 positions for the period ended June 30, 2025.

Company overviewMetricValueAUM30.71 BPrice (as of market close October 7, 2025)$57.32Dividend yield10.4%One-year total return6.0%Company snapshotJPMorgan Nasdaq Equity Premium Income ETF (JEPQ) is a large-scale, income-focused ETF with a market capitalization of $31.11 billion as of October 8, 2025. The fund employs an active options-based strategy to enhance yield while maintaining exposure to leading Nasdaq-100 equities.

Investment strategy focuses on generating income and capital appreciation by actively managing a portfolio of equity securities, primarily those in the Nasdaq-100 Index, and selling call options through equity-linked notes (ELNs).

The portfolio composition reflects the Nasdaq-100 benchmark, with additional income generated from option premiums. It is structured as a non-diversified exchange-traded fund focused on income generation.

Foolish takeSheets Smith's new position in the JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) signals a growing appetite among managers for income-focused equity exposure. JEPQ blends Nasdaq-100 stocks with an options overlay that converts volatility into cash flow. For investors navigating an uncertain rate path, the fund's double-digit yield offers a cushion against a uneven market climate.

JEPQ allows investors to stay in the tech-heavy part of Nasdaq while collecting option premiums that generate monthly income rather than chasing high growth names directly. This structure can appeal to investors prioritizing steady returns over full participation in market rallies. The trade off is that when stocks surge, its capped upside may limit gains. However, that is a fair exchange for steadier returns in a shifting market landscape. 

JEPQ has steadily gained tractions among portfolio managers who value consistent cash flow over chasing every market rally. Its blend of equity exposure and options income gives it power in a world where both growth and yield are hard to find simultaneously. Should markets stay volatile, JEPQ's steady strategy could prove less of a shield and more a path to long term compound growth.

GlossaryExchange-Traded Fund (ETF): An investment fund traded on stock exchanges, holding a basket of assets like stocks or bonds.

Assets Under Management (AUM): The total market value of investments that a fund or firm manages on behalf of clients.

13F Report: A quarterly filing by institutional investment managers disclosing their equity holdings to the SEC.

Dividend Yield: Annual dividends paid by a fund or stock divided by its current price, expressed as a percentage.

Equity-Linked Notes (ELNs): Structured financial products combining fixed-income and equity features, often used to generate income through options.

Call Options: Financial contracts giving the buyer the right to purchase an asset at a set price within a specific period.

Option Premiums: The income received by selling options contracts, often used to enhance yield in investment strategies.

Non-diversified Fund: A fund that invests in a limited number of securities or sectors, increasing potential risk and reward.

Income-Focused ETF: An ETF designed primarily to generate regular income, often through dividends or option strategies.

Active Management: An investment approach where managers make specific buy and sell decisions to outperform the market or benchmark.

Benchmark: A standard, usually an index, against which the performance of a security or fund is measured.

Total Return: The investment's price change plus all dividends and distributions, assuming those payouts are reinvested.

Eric Trie has positions in Nvidia. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy.

Presentation on Tuesday, October 21st at 3:30PM PT
October 17, 2025 2:10 PM EDT | Source: LD Micro
Carlsbad, California--(Newsfile Corp. - October 17, 2025) - Aptera Motors Corp. (NASDAQ: SEV), a solar mobility company pioneering ultra-efficient transportation, announced today that it will be presenting at the 19th annual Main Event on Tuesday, October 21st at 3:30PM PT at the Hotel del Coronado in San Diego, California. Chris Anthony, Co-CEO will be giving the presentation.

"The Main Event is a culmination of over 25 years of hard work and passion for small company investing. There is no organization on planet Earth that cares more about small companies succeeding than LD. To be able to connect with our community in one of the most beautiful settings imaginable brings me considerable joy. We look forward to welcoming all of our patrons and ensuring that they have a wonderful time," stated Chris Lahiji, Founder of LD Micro.

The event will provide an overview of Aptera’s business, mission, and strategy as a leader in the solar EV industry.

Event: LD Micro Main Event XIX
Date: Tuesday, October 21st
Time: 3:30PM

Register to watch the virtual presentation here.

Summary of LD Micro Main Event XIX

The 2025 LD Micro Main Event XIX will run from October 19th to the 21st at the Hotel del Coronado in San Diego, California.

The first day will consist of registration, keynote speakers, and some gorgeous views of the Pacific. It will be followed by two full days of company presentations and one-on-one investor meetings concluded with a closing reception.

This three-day event will feature around 120 companies, presenting in half-hour increments, and attending private meetings with investors.

About Aptera Motors Corp.

Aptera Motors Corp. is a solar mobility company driven by a mission to advance the future of efficient transportation. Its flagship vehicle is a paradigm-shifting solar electric vehicle that leverages breakthroughs in aerodynamics, material science, and solar technology to pursue new levels of efficiency. As a public benefit corporation, Aptera is committed to building a sustainable business that positively impacts its stakeholders and the environment. Aptera is headquartered in Carlsbad, California. For more information, please visit www.aptera.us.

About LD Micro

LD Micro is dedicated to being the definitive resource in the small-cap space. From its industry-recognized index and robust data to hosting some of the most influential events each year, LD Micro’s mission is to provide unparalleled access and insight for those seeking the next generation of great companies.

To learn more about LD Micro, visit:
http://www.ldmicro.com

To learn more about Freedom US Markets LLC, visit:
https://www.freedomcapmkts.com/

To present or register, please contact [email protected].

For further information on Aptera Motors Corp.:

Key Takeaways State Street posted Q3 EPS of $2.78, topping estimates and rising 23% from the prior year.Total revenues grew 8.8% y/y to $3.55B, driven by higher fee income and lower credit provisions.AUC/A hit $51.66T and AUM rose 15.1%, while higher expenses and weaker NII weighed on results.
State Street’s (STT - Free Report)  third-quarter 2025 earnings of $2.78 per share surpassed the Zacks Consensus Estimate of $2.62. The bottom line increased 23% from the prior-year quarter.

Results have been aided by growth in fee revenues and lower provisions. Also, the company witnessed improvements in the total assets under custody and administration (AUC/A) and assets under management (AUM) balances. However, higher expenses and lower net interest income (NII) acted as spoilsports.

Net income available to common shareholders was $802 million, up 17.6% from the year-ago quarter. Our projection for the metric was $698.1 million.

STT’s Revenues Improve, Expenses RiseTotal revenues of $3.55 billion increased 8.8% year over year. The top line surpassed the Zacks Consensus Estimate of $3.47 billion.

NII was $715 million, down 1.1% year over year. The fall was due to lower average short-end rates and deposit mix shift, partially offset by securities portfolio repricing and continued loan growth. Our estimate for the metric was $738.2 million.

The net interest margin (NIM) contracted 11 basis points year over year to 0.96%. We expected NIM to be 0.99%.

Total fee revenues increased 8.1% year over year to $2.83 billion. The rise was driven by an increase in almost all the components, except for lending-related and other fees. We estimated the metric to be $2.70 billion.

Non-interest expenses were $2.43 billion, up 5.5% from the prior-year quarter. The rise was mainly due to an increase in all components, except for the amortization of other intangible assets. Our estimate for non-interest expenses was $2.43 billion.

Provision for credit losses was $9 million, down 65.4% from the prior-year quarter. We had projected the metric to be $20.4 million.

The Common Equity Tier 1 ratio was 11.3% as of Sept. 30, 2025, compared with 11.6% in the corresponding period of 2024. The return on average common equity was 13.4% compared with 12% in the year-ago quarter.

Asset Balances Increase for State StreetAs of Sept. 30, 2025, the total AUC/A was a record $51.66 trillion, up 10.5% year over year. The rise was driven by higher quarter-end equity market levels and client flows. We had projected the metric to be $52.04 trillion.

AUM was $5.45 trillion, up 15.1% year over year, led by higher quarter-end market levels and net inflows. Our estimate for the metric was $5.55 trillion.

STT’s Share Repurchase UpdateIn the reported quarter, State Street repurchased shares worth $400 million.

Our Take on STTRelatively higher interest rates, strategic buyouts, rising AUM and solid business servicing wins are expected to keep supporting STT’s financials. However, persistently rising expenses and concentrated fee-based revenues are concerning.

State Street currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Performance of Other BanksImpressive trading and investment banking (IB) performance drove JPMorgan’s (JPM - Free Report) third-quarter 2025 earnings of $5.07 per share. The bottom line handily surpassed the Zacks Consensus Estimate of $4.83.

JPM’s markets revenues exceeded management's expectations of growth in the high-teens percentage rate. The metric grew 25% year over year to $8.9 billion. Specifically, fixed-income markets’ revenues jumped 21% to $5.6 billion, while equity markets’ numbers increased 33% to $3.3 billion.

Also, the IB business performance was far stronger than that expected by management.

JPMorgan recorded an increase in NII, driven by higher yields and a 7% year-over-year jump in total loans.

Citigroup Inc. (C - Free Report) reported third-quarter 2025 adjusted net income per share of $2.24, up 48.3% from the year-ago period. The metric also surpassed the Zacks Consensus Estimate by 17.3%.

Citigroup’s results benefited from an increase in NII and non-interest revenues, alongside lower provisions. The company also registered a year-over-year increase of 17% in IB revenues, reflecting growth in advisory and equity capital markets. However, increased expenses and a weak capital position were the undermining factors for Citigroup.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of PLD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

The adviser recommends investors reject moonshot pay deal and investment in XAI.

Key Takeaways Fifth Third's Q3 EPS of 93 cents beat estimates and rose from 85 cents a year earlier.
Higher net interest income and fees boosted total revenues 8% y/y.
FITB's loan and deposit balances grew, but credit quality and capital ratios weakened.

Fifth Third Bancorp (FITB - Free Report) reported third-quarter 2025 adjusted earnings per share (EPS) of 93 cents, surpassing the Zacks Consensus Estimate of 87 cents. In the prior-year quarter, the company posted an EPS of 85 cents.

FITB shares rose 2.7% in the early-market trading on better-than-expected results. A full day’s trading session will depict a clearer picture.

Results have benefited from a rise in net interest income (NII), fee income and loan balances. However, higher expenses and weak asset quality were headwinds.

Results included a negative 2-cent impact of certain items. After considering this, the company has reported net income available to common shareholders (GAAP basis) of $608 million, up 14% year over year.

FITB’s Quarterly Revenues & Expenses RiseTotal quarterly revenues (FTE) in the reported quarter were $2.3 billion, which increased 8% year over year. Further, the top line surpassed the Zacks Consensus Estimate by 0.5%.

Fifth Third’s NII (on an FTE basis) was $1.52 billion, up 7% year over year. Our estimate for NII was pegged at $1.51 billion. This improvement was driven by the benefits from proactive deposit and wholesale funding management, decreasing interest-bearing liabilities costs, an improved earning asset mix and the benefit of fixed-rate asset repricing.

The net interest margin (on an FTE basis) increased year over year to 3.13% from 29%. Our estimate for net interest margin was 3.05%.

Non-interest income rose 10% year over year to $781 million. This rise was primarily due to an increase in revenues from wealth and asset management revenues, capital markets fees, and consumer banking revenues. Our estimate for non-interest income was pinned at $769 million.

Non-interest expenses increased 2% year over year to $1.27 billion. The increase was primarily due to a rise in all cost components, except for compensation and benefits, and other non-interest income. Our estimate for the metric was the same as reported.

The efficiency ratio was 54.9%, lower than the year-ago quarter’s 58.2%. A decline in the ratio indicates an improvement in profitability.

FITB Loans & Deposits Balance Increase SequentiallyAs of Sept. 30, 2025, portfolio loans and leases rose slightly to $123.1 billion from the previous quarter. Total deposits inched up 1.4% from the previous quarter to $166.6 billion. Our estimates for portfolio loans and leases and deposits were $116.1 billion and $163.7 billion, respectively.

FITB’s Credit Quality DeterioratesThe company has reported a provision for credit losses of $197 million, up 23% from the year-ago quarter. Our estimate for the metric was pinned at $218 million.

Moreover, the total non-performing portfolio loans and leases were $801 million, up 10.5% year over year.

Net charge-offs in the third quarter increased to $339 million or 1.09% of average loans and leases (on an annualized basis) from $142 million or 0.48% in the prior-year quarter. Our estimate for net charge-offs was $144 million.

The total allowance for credit losses declined 1.1% to $2.42 billion year over year. Our estimate for allowance for credit losses was pinned at $2.63 billion.

Fifth Third’s Capital Position MixedThe Tier 1 risk-based capital ratio was 11.60% compared with 12.07% posted in the prior-year quarter. The CET1 capital ratio was 10.54%, down from 10.75% in the year-ago quarter. The leverage ratio was 9.24% compared with the year-earlier quarter’s 9.11%.

FITB’s Recent DevelopmentThis month, FITB entered a definitive merger agreement to acquire Comerica Incorporated (CMA - Free Report) . The impending acquisition serves as a strategic acceleration of Fifth Third’s long-term growth plan, enhancing scale, profitability and geographic reach.  

This transaction, expected to close at the end of the first quarter of 2026, will bring together two banking franchises to create the ninth-largest U.S. bank with nearly $288 billion in assets, $224 billion in deposits and $174 billion in loans.

Financially, the deal is projected to boost FITB’s earnings per share by 9% by 2027, while driving the combined efficiency ratio into the low-to-mid-50% range, roughly 200 basis points better than the current performance levels.

Our Viewpoint on Fifth ThirdA rise in NII, driven by loan growth, deposit rate management, and fixed-rate asset repricing, supported top-line growth. The company’s ongoing investments in growth priorities continue to drive robust results. However, higher expenses and weak asset quality remain near-term concerns.

Fifth Third Bancorp Price, Consensus and EPS Surprise

Currently, Fifth Third carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Performance of Other BankHancock Whitney Corp.’s (HWC - Free Report) third-quarter 2025 earnings per share of $1.49 exceeded the Zacks Consensus Estimate of $1.41. Further, the bottom line rose 12% from the prior year quarter.

HWC’s results benefited from an increase in non-interest income and net interest income alongside lower provisions. Also, higher loans were another positive. However, higher adjusted expenses and lower deposit balances were headwinds. 

Q4: 2025-10-16 Earnings SummaryEPS of $0.72 misses by $0.05

 |

Revenue of

$188.30M

(-0.21% Y/Y)

misses by $2.27M

WaFd, Inc. (NASDAQ:WAFD) Q4 2025 Earnings Call October 17, 2025 10:00 AM EDT

Company Participants

Brad Goode - Chief of Communications, Marketing & Community Relations and Senior VP
Brent Beardall - President, CEO & Vice Chairman
Kelli Holz - Executive VP & CFO
Ryan Mauer - Executive VP & Chief Credit Officer
Cathy Cooper - Executive VP, Chief Experience Officer & Corporate Secretary

Conference Call Participants

Jeff Rulis - D.A. Davidson & Co., Research Division
Matthew Clark - Piper Sandler & Co., Research Division
Andrew Terrell - Stephens Inc., Research Division
Kelly Motta - Keefe, Bruyette, & Woods, Inc., Research Division

Presentation

Operator

Good day, and thank you for standing by. Welcome to the WaFd Fourth Quarter and Fiscal Year 2025 Results Call. [Operator Instructions] Please be advised today's conference is being recorded. I would now like to hand this conference over to your speaker today, Brad Goode. Please go ahead.

Brad Goode
Chief of Communications, Marketing & Community Relations and Senior VP

Thank you, Kevin. Good morning, everybody. We are excited to have you all attending our first ever earnings conference call. We have listened to the feedback from many of you requesting that we hold a call like this, we've heard you, and so here we are. Let's dive into our 2025 fourth quarter and full year earnings report. You can find our earnings press release, along with our detailed fact sheet and investor scorecard on our website, I'm sure you all know where that is, wafdbank.com.

During today's call, we will make some forward-looking statements, which are subject to risks and uncertainties and are intended to be covered by the safe harbor provisions of federal securities law. Information on risk factors that could cause actual results to differ are available from the earnings press release that was released yesterday and the recently filed Form 10-Q

Recommended For You

Scan QR code to install app

Important DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your own due diligence checks, apply your own discretion and consult your competent advisors. The content of the website is not personally directed to you, and we does not take into account your financial situation or needs.The information contained in this website is not necessarily provided in real-time nor is it necessarily accurate. Prices provided herein may be provided by market makers and not by exchanges.Any trading or other financial decision you make shall be at your full responsibility, and you must not rely on any information provided through the website. FX Empire does not provide any warranty regarding any of the information contained in the website, and shall bear no responsibility for any trading losses you might incur as a result of using any information contained in the website.The website may include advertisements and other promotional contents, and FX Empire may receive compensation from third parties in connection with the content. FX Empire does not endorse any third party or recommends using any third party's services, and does not assume responsibility for your use of any such third party's website or services.FX Empire and its employees, officers, subsidiaries and associates, are not liable nor shall they be held liable for any loss or damage resulting from your use of the website or reliance on the information provided on this website.Risk DisclaimersThis website includes information about cryptocurrencies, contracts for difference (CFDs) and other financial instruments, and about brokers, exchanges and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and come with a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money.FX Empire encourages you to perform your own research before making any investment decision, and to avoid investing in any financial instrument which you do not fully understand how it works and what are the risks involved.

Ford is recalling nearly 625,000 US vehicles over safety issues with the seat belts and camera displays that could increase the risk of a crash or injuries, the National Highway Traffic Safety Administration said Friday.

Certain 2015-2017 Ford Mustang vehicles are being recalled for faulty seat belt anchor cables that can corrode over time and break. This recall includes 332,778 units.

Water and salt from the road may corrode the front seat belt pretensioner cables, Ford said.

Ford is recalling nearly 625,000 US vehicles over safety issues with the seat belts and camera displays. Getty Images
This can cause the cables to break, preventing the seat belt from properly restraining passengers and thus increasing the risk of injury in a crash.

Owners should bring their vehicles to a dealership, where the front seat belt cables can be inspected and replaced if needed, free of charge.

Dealers will also remove sections of the carpet that come into contact with the cables.

Letters notifying owners of the safety risk are expected to be mailed sometime this month.

Additional letters will be sent once the final remedy is available, likely in January 2026.

Certain 2020-2022 F-250 SD, F-350 SD, and F-450 SD vehicles are being recalled for a faulty rearview camera image.

This recall includes 291,901 units, and estimates all of them have the defect.

The 360-degree view camera system may not properly display a rearview image in certain lighting conditions, appearing severely underexposed or overexposed.

The camera glitch could prevent the driver from clearly seeing the view behind their vehicle, increasing the risk of a crash, the automaker said in a recall report.

Water and salt from the road may corrode the front seat belt pretensioner cables, Ford said. Serg – stock.adobe.com
Owners should bring their vehicles to a dealership, where the image processing software will be updated, free of charge.

Ford said it expects to send letters notifying owners of the safety risk by Oct. 20, 2025.

Additional letters will be mailed when the final remedy is available, likely by March 2026.

The company said it is not aware of any accidents or injuries related to this recall.

It’s just the latest recall this year in a heavy batch for Ford, one of the “Big Three” automakers based near Detroit, Mich.

Certain Ford F-350’s are being recalled for a faulty rearview camera image. jetcityimage – stock.adobe.com
In the first six months of 2025, Ford issued more safety recalls than any other car company has in an entire calendar year, according to the Wall Street Journal.

The automaker has either reported the highest or second-highest number of recalls industry-wide each year since 2020.

The automaker issued 88 safety recalls through the end of June, according to federal data. It has recorded about 120 recalls so far this year.

ToplineLarry Ellison, the world’s second-richest person, had roughly $24 billion cut from his net worth as shares of his Oracle tumbled on Friday, despite executives providing revenue growth forecasts that were applauded by Wall Street.

Oracle’s chairman challenged Elon Musk for the world’s richest title following a record-breaking rally last month.

Copyright 2025 The Associated Press. All rights reserved

Key FactsShares of Oracle dropped about 7% to around $291 by Friday afternoon, pacing what would be the stock’s second-largest plunge this year.

Oracle executives, including Ellison and CEO Clay Magouyrk, among others, spoke with analysts late Thursday and forecasted revenue to grow at an average of 31% annually over the next five years, with sales expected to hit $225 billion by fiscal year 2030.

Executives said earnings are projected to increase to $21 per share by fiscal year 2030, an average of 28% annual growth.

The forecasts were celebrated among economists: Barclays analyst Raimo Lenschow wrote the estimates pulled ahead of Wall Street’s projections, while Guggenheim’s John DiFucci said growth estimates were “much higher than some have speculated.”

A stock slide could be attributed to Oracle executives failing to provide additional details about capital expenditure plans, Jefferies analyst Brent Thill wrote Thursday, noting there was “no-forward-looking commentary” on expenditures and that estimates would need to “ramp” in line with Oracle’s cloud infrastructure revenue growth.

Forbes ValuationEllison, who holds about 41% equity in Oracle, remains the second-wealthiest person in the world with a fortune estimated at $350.6 billion. The stock decline dropped about $24.1 billion from Ellison’s net worth, representing a 6.3% decrease. He trails Elon Musk for the world’s richest title, as the Tesla CEO’s net worth swells toward the $500 billion threshold once again, settling at $485.9 billion as of Friday. Ellison came within the ballpark of Musk’s fortune last month after Oracle shares soared the most since 1992, adding $110 billion to Ellison’s net worth in a single day as the Oracle chairman became the second person to ever eclipse $400 billion.

How High Could Oracle’s Stock Go?Despite pointing to a lack of answers on Oracle’s capital expenditures, Thill raised his price target for Oracle’s stock to $400 from earlier estimates of $360. DiFucci and Lenschow similarly raised their price targets to $400 from $375 and $367, respectively, maintaining a bullish outlook while Stifel analyst Brad Reback held his $350 price target.

Key BackgroundOracle’s stock has accelerated in recent months as the cloud computing giant has forecast significant revenue growth on AI demand. Last month, Oracle projected cloud infrastructure revenue to increase to $18 billion this fiscal year before nearly doubling to $32 billion in 2027, before hitting $73 billion, $114 billion and $144 billion over the following three years. The company also reported a 359% increase in contracted revenue that has yet to be recognized to $455 billion, after Oracle said it reached four multibillion-dollar contracts with three different customers through its latest quarter. Those estimates surprised analysts, including Deutsche Bank’s Brad Zelnick, who wrote that those on a call with Oracle executives at the time were “all kind of in a shock in a very, very good way,” as there was “no better evidence of a seismic shift happening in computing.”

Further Reading

As Salesforce (CRM) wraps up its Dreamforce event, Cory Johnson talks about the software giant's path forward. He notes the importance of free cash flow and the role agentic A.I.

Key Highlights

Major macroeconomic and geopolitical shifts during the quarter are reshaping the Western mine-to-magnet industryThe Halleck Creek Rare Earths Project represents a long-term, strategic solution to securing America’s rare earths supply Why it Matters

The Halleck Creek Rare Earths Project: A Wyoming Solution to Diversify and De-Risk the United States’ Upstream Rare Earths Supply Chain

DENVER, Oct. 17, 2025 (GLOBE NEWSWIRE) -- The Trump Administration has made significant and meaningful investments in reshoring the United States’ rare earths industry. However, the rapidly developing U.S. mine-to-magnet industry still has a single point of failure as there is only one domestic rare earths mine currently in production in the United States. Without additional domestic rare earths mines to diversify supply, the growing domestic magnetics industry (incentivized by the US government) remains exposed to supply chain vulnerabilities given the current concentration of global upstream rare earths mining and refining capacity in China.

American Rare Earths (“ARR”) (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) (“ARR” or the “Company”) offers a Wyoming-based solution, the Halleck Creek Rare Earths Project, a mine to magnet project that can diversify, de-risk, and ultimately supply the United States, and its allies, rare earths magnetics industries with the necessary light and heavy rare earths feedstock for the next 100+ years. American Rare Earths applauds the Department of Defense collaboration with MP Materials to construct the 10,000 tonnes per annum Independence Magnetics Facility. However, if the Mountain Pass mine remains the sole domestic supply of mined feedstock, the domestic rare earths market remains at risk. Based on the most recent technical study undertaken by ARR1, Halleck Creek’s initial base case production could fulfil upwards of 57% of the light rare earths (i.e. Neodymium-Praseodymium or “NdPr”) and 30% of the critical heavy rare earths (i.e Dysprosium, “Dy”, and Terbium, “Tb”) feedstock necessary to supply the Independence Magnetics facility for generations. Halleck Creek is America’s long-term rare earths supply solution.

ARR reports continued advancement at its flagship Halleck Creek Rare Earths Project in Wyoming for the quarter ending September 30, 2025. This report summarizes progress in test mining, process optimization, permitting and corporate initiatives during the period, with workstreams supporting design of a beneficiation demonstration plant and the permit-to-mine submission.

During the quarter the Company achieved many technical milestones which materially de-risk Halleck Creek’s development and move the Project closer to becoming the United States next producing rare earths mine. American Rare Earths strongly believes Halleck Creek is the solution to diversify and de-risk the United States’ upstream rare earths supply chain for generations to come.

Project Development and Permitting Milestones

Allanite Rare Earths Hydrometallurgical Processing Breakthrough: Successful Completion of the Impurity Removal Neutralization Test (October 13, 2025)

Impurity removal is one of the last steps in the hydrometallurgical processing of rare earths elements (“REE”) and is performed to remove non-REE minerals from the leach liquor prior to solvent extraction and separation (i.e. the final steps before producing rare earths oxide). Historically, this has been a challenging step for processing allanite-based REEs, like Halleck Creek’s ore, as the mineral typically produces unwanted byproducts such as gypsum and silica gel, resulting in additional and difficult processing steps to remove them.In a recent and extensive impurity removal test program on Halleck Creek ore minimal gypsum and silica gel were formed during the process, which points to immense operating benefits, including but not limited to the reduction of rare earths yield loss and fewer processing steps resulting in potentially lower capital and operating expenses.These results de-risk what has historically been a material technical and economic hurdle in the processing of allanite-based rare earths elements (i.e. Halleck Creek’s ore) and represent a major milestone in unlocking Halleck Creek’s vast REE supply potential. Strong Recoveries and Low Impurities Shown in Extensive Leach Testing of Halleck Creek Ore (July 9, 2025)

High Light Rare Earths Leach Recoveries Praseodymium (“Pr”) leach recoveries of 85% at optimal conditionsNeodymium (“Nd”) leach recoveries of 84% at optimal conditions Encouraging Heavy Rare Earths Leach Recoveries Terbium (“Tb”) leach recoveries of 52% at optimal conditionsDysprosium (“Dy”) leach recoveries of 46% at optimal conditions Significantly lower impurity elements of iron and aluminum Concentrations of iron and aluminum impurities post leach are approximately 5.0x and 2.9x, respectively, lower than the tests previously performed for the Scoping Study Atmospheric Tank Leach chosen as the preferred leach method Atmospheric tank leaching is typically more energy and reagent efficient and less costly than other rare earth leaching methods, such as an acid-bake (i.e. cracking) Test Mining Completed at The Cowboy State Mine (CSM), Optimization Tests Underway (September 23, 2025 and July 18, 2025)

Excavation and primary crushing of approximately 3,080 tonnes of ore was successfully and safely completed under the Company’s Wyoming exploration license. The extracted material will be used for both mineral processing optimization testing and as a stockpile for a future demonstration plant.Optimization testing underway with bulk samples dispatched to comminution experts in the U.S., Canada and Germany. Optimization tests will target low-effort, but high yield opportunities to increase overall rare earth magnet element recoveries and strengthen overall project economics. Permitting Progress at Halleck Creek (August 26, 2025)

Groundwater pump test completed at the CSM area to provide baseline data for the Wyoming Department of Environmental Quality permit-to-mine application.Environmental monitoring and hydrological modelling continuing as part of PFS and permitting requirements. Corporate and Funding Milestones (July 24, 2025 & October 2, 2025)

Robust cash position with funding secured for planned activities over the next 18-24 monthsA$15m placement completed in July 2025 at A$0.32 per share with strong institutional participation. Proceeds to fund a beneficiation demonstration-plant construction, in-fill drilling, and engineering programs.A$1.465m raised via the exercise of options in July and August 2025Post quarter end, ARR announces receipt of the final payment of A$1m, together with accrued interest, from Cobalt Blue Holdings Limited under the terms of the Promissory Note.At September 30, 2025, the Company has available approximately A$8.8m (US$5.6m) remaining under the State of Wyoming matching grant. Outlook

In the December 2025 quarter, American Rare Earths will focus on integrating results from ongoing optimization testwork into the Halleck Creek Pre-Feasibility Study (“PFS”) and beneficiation demonstration-plant design. Engineering and equipment planning will progress in parallel, with the goal of finalizing a robust mineral processing flowsheet for the PFS, followed by the publication of the technical report in 2026. Environmental and permitting activities will continue, including completion of the groundwater model and submission preparations for the Wyoming Department of Environmental Quality permit-to-mine application.

At the corporate level, the Company will continue to advance CEO recruitment and strengthen engagement with U.S. Federal and State agencies involved in critical-minerals strategy and funding programs. ARR remains focused on continuing to develop and de-risk the Halleck Creek project, with the goal of becoming the United States’ next producing rare earths mine to support the rapidly growing magnetics industry.

Strong Cash Position

At September 30, 2025, the Company had a cash position of A$21.2m and financial assets associated with ASX listed Cobalt Blue Holdings and Godolphin Resources of A$1.8m.

The Company had net cash expenditure of A$1.4m for operating costs and A$2.3m for project development (net of reimbursement from the Wyoming Energy Authority grant) activities during the quarter.

Post quarter end, the Company announced the receipt of the final payment of A$1m plus accrued interest from COB under the terms of the Promissory Note. Since the end of the quarter to the date of this release, the Company has raised a further A$3.495m via the exercise of 9m options.

Payments to related parties are included in item 6 of the Appendix 5B. Item 6.1 relates to payment of managing director salary, non-executive directors’ fees, superannuation and consulting fees for the quarter. Also included in the Sept 25 quarter are payments made in respect to the resignation of former Managing Director and CEO, Mr. Chris Gibbs, effective July 31, 2025.

This announcement has been authorized for release by the Board of American Rare Earths Limited.

Investors can follow the Company’s progress at www.americanree.com.

About American Rare Earths Limited:

American Rare Earths (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) is a critical minerals company at the forefront of reshaping the U.S. rare earths industry. Through its wholly owned subsidiary, Wyoming Rare (USA) Inc. (“WRI”), the company is advancing the Halleck Creek Project in Wyoming—a world-class rare earth deposit with the potential to secure America’s critical mineral independence for generations. Located on Wyoming State land, the Cowboy State Mine within Halleck Creek offers cost-efficient open-pit mining methods and benefits from streamlined permitting processes in this mining-friendly state.

With plans for onsite mineral processing and separation facilities, Halleck Creek is strategically positioned to reduce U.S. reliance on imports—predominantly from China—while meeting the growing demand for rare earth elements essential to defense, advanced technologies, and economic security. As exploration progresses, the project’s untapped potential on both State and Federal lands further reinforces its significance as a cornerstone of U.S. supply chain security. In addition to its resource potential, American Rare Earths is committed to environmentally responsible mining practices and continues to collaborate with U.S. Government-supported R&D programs to develop innovative extraction and processing technologies for rare earth elements.

For further information contact:

_______________________
1 ASX release dated 24 February 2025

JNJ's strong Q3 results, upbeat sales outlook and expanding drug pipeline highlight resilience despite Stelara LOE.

KeyCorp (NYSE:KEY) posted better-than-expected earnings for the third quarter on Thursday.

The company posted adjusted earnings of 41 cents per share, beating market estimates of 38 cents per share. The company's quarterly sales came in at $1.895 billion versus expectations of $1.881 billion.

KeyCorp's Chairman and CEO, Chris Gorman, said, “Our third quarter results demonstrate continued strong momentum. Adjusted revenue was up 17% year-over-year, and we generated more than 1,000 basis points of operating leverage again this quarter. Revenue growth was driven by our clearly defined net interest income tailwinds and adjusted noninterest income growth of 8%, which continues to grow faster than expenses. At the same time, we continue to make meaningful investments in front line bankers and technology that will drive future growth. Tangible book value per share grew 4% sequentially and 14% year-over-year.”

KeyCorp shares gained 0.6% to trade at $16.88 on Friday.

These analysts made changes to their price targets on KeyCorp following earnings announcement.

Truist Securities analyst Brian Foran maintained KeyCorp with a Hold and lowered the price target from $20 to $19.
DA Davidson analyst Peter Winter maintained the stock with a Buy and lowered the price target from $22 to $21.
Considering buying KEY stock? Here’s what analysts think:

Read This Next:

How To Earn $500 A Month From Steel Dynamics Stock Ahead Of Q3 Earnings
Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

By

Bill McColl

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of the most notable news stories of the time.

Published October 17, 2025

12:28 PM EDT

American Express shares climbed after the company posted strong quarterly results.
Scott Olson / Staff / Getty Images

Key Takeaways
Major U.S. equities indexes climbed at midday Friday as regional bank stocks rebounded from yesterday's losses after a flurry of corporate earnings reports.American Express shares climbed after the company posted strong quarterly results.Novo Nordisk and Eli Lilly shares lost ground after President Trump said he would look to lower prices for popular weight-loss drugs.

Major U.S. equities indexes climbed at midday Friday as regional bank stocks rebounded from yesterday's losses after a flurry of corporate earnings reports. The Dow, S&P 500, and Nasdaq were all higher.

Kenvue (KVUE) was the best-performing stock in the S&P 500 as investors bought the dip in the health care product’s stock following yesterday’s selloff after a lawsuit in the U.K. claimed the company’s baby powder caused cancer.

Shares of American Express (AXP) gained after the financial firm posted quarterly results that topped analysts' estimates and lifted its outlook as customers rushed to use its refreshed high-end credit cards.

Truist Financial (TFC) also posted better-than-expected results on higher wealth management fees and interest income, sending its shares higher.

Shares of Newmont (NEM) and rival gold miners slid as the price of the precious metal, which has been setting records recently, pulled back.

U.S.-listed shares of Novo Nordisk (NVO) and shares of Eli Lilly (LLY) were down following comments from President Trump about slashing prices for popular weight-loss drugs.

The yield on the 10-year Treasury note and oil futures edged higher. The U.S. dollar gained on the euro and pound, but lost ground to the yen. Most major cryptocurrencies traded lower. 

Do you have a news tip for Investopedia reporters? Please email us at

[email protected]

Partner Links

Top Stock Movers Now: AMD, Morgan Stanley, Bank of America, Progressive, and More

Top Stock Movers Now: AMD, Arm, Levi Strauss, and More

Top Stock Movers Now: Salesforce, J.B. Hunt, Hewlett Packard Enterprise, and More

Top Stock Movers Now: Ford, AppLovin, AMD, and More

Top Stock Movers Now: Walmart, Intel, Domino's Pizza, Arista Networks, and More

S&P 500 Gains and Losses Today: Regional Banks Slump on Worries About Bad Loans; Data Storage Stocks Surge

Top Stock Movers Now: Nvidia, AMD, Dell, Fair Isaac, and More

S&P 500 Gains and Losses Today: Dell Retreats; Delta Leads Airlines Higher

Top Stock Movers Now: AMD, Tesla, Comerica, Verizon, and More

Top Stock Movers Now: Delta Air Lines, PepsiCo, Akero Therapeutics, and More

Top Stock Movers Now: Nvidia, Apple, Kenvue, and More

Top Stock Movers Now: Intel, AMD, Starbucks, Fair Isaac, and More

Top Stock Movers Now: Nike, Eli Lilly, Corteva, AES, and More

What to Expect in Markets This Week: Big Bank Earnings, Fed Speakers, Shutdown Data Delays

S&P 500 Gain & Losses Today: Oracle, Nvidia Shares Advance; Kenvue Stock Slips

Top Stock Movers Now: Electronic Arts, Western Digital, Intel, and More

Key Takeaways Gardasil sales plunged 48% year over year to $2.45 billion during the first half of 2025.Merck halted Gardasil shipments to China until at least 2025-end amid excess partner inventory.Economic weakness in China and soft demand in Japan weigh on Gardasil's sales outlook.
Merck (MRK - Free Report) is facing persistent challenges for its second-largest product, Gardasil, which is a vaccine for the prevention of certain cancers caused by human papillomavirus. Though the vaccine’s sales rose consistently till 2022, it started witnessing sluggish sales from 2024.

During the first half of 2025, Gardasil sales declined 48% on a year-over-year basis to $2.45 billion. Sales of Gardasil are declining due to weak performance in China, which resulted from sluggish demand trends amid an economic slowdown. Lower demand in China resulted in above-normal channel inventory levels at Merck’s commercialization partner in China, Zhifei.

Accordingly, Merck decided to temporarily halt shipments of Gardasil in China to allow Zhifei to burn down existing inventory. Merck does not expect to resume shipments to China through at least the end of 2025.

Gardasil sales are expected to decline significantly in 2025 from 2024 levels.

Merck is also seeing lower demand for Gardasil in Japan. Management expects Gardasil sales to remain weak in China as well as Japan in the third and fourth quarters of 2025. Our estimates for Gardasil sales suggest a negative CAGR of 15.1% over the next three years.

MRK's Other Vaccines & Competition in the Target MarketBesides Gardasil, Merck markets other vaccines like ProQuad/ M-M-R II/Varivax (measles, mumps, rubella and varicella virus vaccine, Vaxneuvance (pneumococcal 15-valent conjugate vaccine), RotaTeq (rotavirus vaccine), Pneumovax 23 (pneumococcal vaccine polyvalent) and its newest jab, Capvaxive (21-valent pneumococcal conjugate vaccine).

Sales of other vaccines like Proquad, M-M-R II, Varivax, Rotateq and Pneumovax 23 also declined during the first half of 2025.

Merck’s newest respiratory syncytial virus (RSV) antibody, Enflonsia (clesrovimab), was approved in the United States in June 2025, while it is under review in the EU. Merck is currently gearing up to launch Enflonsia to help protect infants entering their first RSV season.

Per management, Enflonsia is the first and only treatment option designed to protect infants with the same dose regardless of weight.

However, Enflonsia is likely to face stiff competition from AstraZeneca (AZN - Free Report) /Sanofi’s (SNY - Free Report) RSV antibody Beyfortus, which was approved for a similar indication in 2023.

AstraZeneca records a 50% share of gross profits on sales of Beyfortus in major markets outside the United States and 25% of brand revenues in the rest of the world markets received from partner Sanofi as Alliance revenues.

Beyfortus achieved blockbuster status in its first full year of sales in 2024.

Besides antibodies, some vaccines have been approved for preventing RSV in certain patients in the United States. These include Pfizer’s Abrysvo, GSK’s Arexvy and Moderna’s mRESVIA.

MRK's Price Performance, Valuation and EstimatesYear to date, shares of Merck have declined 15.8% against the industry’s rise of 5.6%. The stock has also underperformed the sector and the S&P 500 during the same time frame, as seen in the chart below.

Image Source: Zacks Investment Research

From a valuation standpoint, Merck appears attractive relative to the industry. Going by the price/earnings ratio, the company’s shares currently trade at 8.97 forward earnings, lower than 15.62 for the industry and its 5-year mean of 12.64.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for 2025 earnings per share has decreased from $8.94 per share to $8.92, while the same for 2026 has decreased from $9.55 to $9.44 over the past 60 days.

Image Source: Zacks Investment Research

MRK's Zacks RankMerck currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Bryn Talkington, Managing Partner of Requisite Capital Management, joins CNBC's "Halftime Report" to explain why she's selling IonQ.

Key Takeaways Visa's revenues rose 14.3% to $10.2B, backed by strong cross-border volumes and consumer spending.Affirm's GMV soared 43% to $10.4B, with active consumers up 24% to 23M and 95% repeat usage.Visa gained 15.4% in a year, while Affirm's 55.1% rally reflects BNPL's fast-rising market traction.
The payments world is in the middle of a dramatic transformation. For decades, credit card titans like Visa Inc. (V - Free Report) ruled the global transaction network, setting the gold standard for speed, security and reliability. Now, the rise of digital-first players such as Affirm Holdings, Inc. (AFRM - Free Report) is rewriting the rules, offering consumers flexible, transparent and often interest-free ways to finance their purchases.

As shoppers increasingly move away from traditional credit toward installment-based models, the “buy now, pay later” (BNPL) revolution has become one of the most powerful forces reshaping modern finance. Visa remains a fortress of profitability and scale, while Affirm represents the tech-savvy challenger catering to new-age consumers who value clarity and choice over revolving debt.

It is a classic matchup of legacy dominance versus digital disruption: Visa, the credit card king that built the past, against Affirm, the BNPL upstart defining the future. So, who is better positioned to ride the next great wave in payments? Let’s dive in.

The Case for VisaVisa’s dominance across the global payments landscape is unrivaled. Operating in more than 200 countries, Visa processes an enormous share of the world’s transactions, expected to surpass 257 billion in fiscal 2025. That scale forms the foundation of its durable business model: Visa earns high-margin revenue through transaction fees, licensing and value-added services, without taking on direct credit risk like lenders do.

In the last reported quarter, Visa’s net revenues climbed 14.3% year over year to $10.2 billion, powered by robust cross-border volumes and strong consumer spending resilience. Payments volume grew 8%, while cross-border transactions rose 12%, underscoring the strength of global commerce. Adjusted operating income rose 14.9% to $6.9 billion, keeping Visa’s margins comfortably close to 68%.

Its balance sheet remains pristine, with a long-term debt-to-capital ratio of just 33.6%, far lower than Affirm’s 71.8%. That financial strength gives Visa tremendous flexibility to invest, repurchase shares, and weather downturns.

However, the payments landscape is evolving quickly. Younger consumers are gravitating toward flexible, short-term payment options instead of revolving credit cards. That trend plays directly into the hands of BNPL players like Affirm. Moreover, Visa’s growth in mature markets is expected to slow as card penetration approaches saturation, limiting upside compared with nimble fintechs expanding into new segments.

Regulatory scrutiny is also intensifying. Authorities in the United States and the U.K. have raised concerns about the duopoly between Visa and Mastercard Incorporated (MA - Free Report) , which could constrain their pricing power or invite legal challenges.

To its credit, Visa is not standing still. It continues to invest in tokenization, real-time payments and BNPL partnerships, while experimenting with blockchain and stablecoin-powered cross-border settlements. The latter is expected to be transformative, reducing friction, cutting costs and freeing up capital trapped in banking intermediaries.

Visa currently trades below its average analyst price target of $398.16, implying 15.2% upside. Yet, compared with Affirm’s faster growth and higher return potential, Visa may represent steady reliability rather than explosive opportunity. Affirm trades below its average analyst price target of $95.50, leaving a potential for 30.7% upside.

The Case for AffirmAffirm has rapidly become one of the most recognized names in BNPL, a category that is redefining how consumers pay for everything from electronics to groceries. The company’s transparent, interest-free installment loans appeal to shoppers wary of credit card debt, while merchants benefit from higher conversion rates and average order values.

Affirm’s merchant network spans more than 377,000 partners, including household names like Amazon, Shopify and Costco, giving it prime visibility at the digital checkout counter. That integration ensures millions of consumer touchpoints daily, strengthening brand loyalty and usage frequency. Its latest results tell a story of momentum and scale. In the fourth quarter of fiscal 2025, Affirm’s gross merchandise volume (GMV) soared 43% year over year to $10.4 billion, driven by rising transaction frequency and broader category adoption. Active consumers climbed 24% to 23 million, and the repeat transaction rate hit 95%, underscoring high customer satisfaction and stickiness.

Affirm’s edge lies in its data-driven underwriting model, powered by AI algorithms that assess real-time credit risk. This has helped reduce delinquency even as it expands. While profitability remains a work in progress, the company’s improving operating efficiency and expanding scale are boosting margins steadily. Importantly, its strategic push into everyday purchases, travel, gaming and small-ticket items opens the door to recurring, high-frequency usage, a key to sustainable growth.

Affirm does face competition from established networks and other BNPL providers like Klarna Group plc (KLAR - Free Report) and Afterpay. Walmart’s decision to shift from Affirm to Klarna highlighted how fragile those relationships can be. Still, Affirm’s transparent fee structure, strong brand identity, and deep API integration with retailers make it one of the most trusted BNPL platforms in the market. In an era where consumers crave financial flexibility and transparency, Affirm’s technology-first strategy and strong merchant ties give it a unique growth runway. As Visa adapts to protect its turf, Affirm is sprinting ahead to capture the next generation of digital spenders.

How Do Zacks Estimates Compare for V & AFRM?While Visa’s growth outlook is steady, Affirm’s projections reflect a company in transformation, one that is scaling toward sustainable profitability and expanding its total addressable market.

The Zacks Consensus Estimate for Visa’s fiscal 2025 earnings is pegged at $11.43 per share, a 13.7% year-over-year growth, reflecting solid but mature expansion. Revenues for the current year are expected to reach $39.8 billion, a jump of 10.9% from a year ago. It beat earnings estimates in each of the past four quarters with an average surprise of 3.9%.

In contrast, Affirm’s fiscal 2026 earnings estimate stands at 85 cents per share, marking a remarkable 466.7% surge year over year, while revenues are expected to jump 23.8%. AFRM has also beaten earnings estimates in each of the past four quarters, but with an average surprise of 105.5%.

Valuation: V vs. AFRMOn a price-to-sales basis, Visa sits at 13.86X forward revenues, significantly above Affirm’s multiple of 5.29X. Affirm’s cheaper P/S multiple leaves room for significant growth as business expansion accelerates.

Image Source: Zacks Investment Research

Price Performance ComparisonVisa has returned 15.4% in the past year, buoyed by resilient spending trends and market optimism. Affirm, on the other hand, has delivered a stunning 55.1% return, riding the tailwinds of surging BNPL adoption and operational improvements. The S&P 500 gained 16.2% during the same period.

Price Performance – V, AFRM & S&P 500
Image Source: Zacks Investment Research

ConclusionVisa remains a financial titan, steady, profitable, and globally dominant. But the payments ecosystem is evolving, and consumers are rewriting the rules of credit. Affirm’s rapid growth, advanced underwriting, and expanding merchant network position it to benefit directly from this generational shift.

While Visa continues to deliver consistent returns, Affirm looks better poised for outsized gains, thanks to its business model and long runway for adoption. For investors betting on where payments are headed next, the BNPL rebel is likely to just outpace the credit card king. Affirm currently has a Zacks Rank #2 (Buy), while Visa has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Key Takeaways Avantor entered a strategic partnership with BlueWhale Bio to advance CAR-T manufacturing.The collaboration merges Avantor's bioprocessing expertise with BlueWhale's CDNP technology.The deal targets scalable, efficient CAR-T production and strengthens Avantor's cell therapy presence.
Avantor (AVTR - Free Report) recently entered into a strategic partnership with BlueWhale Bio to accelerate innovation in CAR-T cell therapy manufacturing. The collaboration merges Avantor’s bioprocessing expertise with BlueWhale’s proprietary Synecta cell-derived nanoparticle (CDNP) technology to streamline cell activation and expansion.

The partnership aims to address key bottlenecks in CAR-T production by enhancing scalability, reducing variability and shortening time-to-patient. Together, the companies plan to deliver next-generation manufacturing solutions that expand patient access and strengthen Avantor’s footprint in the fast-growing cell therapy market.

Likely Trend of AVTR Stock Following the NewsFollowing the announcement, the company's shares traded flat at yesterday’s closing. In the year-to-date period, shares have lost 30.8% against the industry’s 0.5% growth. The S&P 500 has gained 14.5% in the same time frame.

In the long term, the BlueWhale Bio partnership could strengthen Avantor’s position in the high-growth cell and gene therapy market by expanding its portfolio of advanced bioprocessing solutions. By integrating cutting-edge CAR-T manufacturing technologies, Avantor can deepen its presence with biotech and pharma clients, capture higher-margin opportunities in GMP-grade reagents, and drive recurring revenue from next-generation therapy platforms—supporting sustainable growth and long-term shareholder value.

AVTR currently has a market capitalization of $9.46 billion.

Image Source: Zacks Investment Research

More on the PartnershipFor Avantor, the partnership with BlueWhale Bio marks a strategic step toward deepening its role in the fast-evolving cell therapy manufacturing landscape. Avantor will leverage its bioprocessing and GMP-grade reagent production capabilities to scale up BlueWhale’s CDNP platform, a breakthrough designed to mimic natural T-cell stimulation. Data from BlueWhale Bio’s preclinical and clinical programs show earlier cell division, higher cell yields, and fewer process interventions, suggesting the potential to shorten CAR-T production time while minimizing cell stress during manufacturing. The technology is already being used in a clinical trial featuring a three-day CAR-T manufacturing process, underscoring its promise for accelerating therapy turnaround and expanding patient access.

This collaboration allows Avantor to integrate cutting-edge activation and expansion reagents into its global manufacturing ecosystem, reinforcing its reputation as a critical enabler of next-generation therapies. By combining its scale, supply reliability, and regulatory expertise with BlueWhale Bio’s scientific innovation, Avantor is well-positioned to deliver a differentiated manufacturing solution for CAR-T developers. Over time, this could enhance Avantor’s presence in high-growth markets, strengthen long-term customer partnerships, and open new avenues for value creation as demand for efficient, scalable cell therapy production continues to rise globally.

Favorable Industry Prospects for AVTRPer a report by Grand View Research, the global cell and gene therapy manufacturing market size was valued at $7.28 billion in 2022 and is expected to witness a CAGR of 26.6% from 2023 to 2030.

AVTR’s Zacks Rank & Key PicksCurrently, AVTR carries a Zacks Rank #4 (Sell).

Some better-ranked stocks in the broader medical space are Masimo (MASI - Free Report) , Merit Medical System (MMSI - Free Report) and West Pharmaceutical Services (WST - Free Report) . Each stock presently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Masimo shares have lost 10.4% so far this year compared with the industry’s 7.4% decline. Estimates for the company’s 2025 earnings per share have increased 1.3% to $5.30 in the past 30 days.

MASI’s earnings beat estimates in each of the trailing four quarters, the average surprise being 13.8%. In the last reported quarter, it posted an earnings surprise of 8.1%.

Estimates for Merit Medical’s 2025 earnings per share have increased 0.8% to $3.63 in the past 60 days. Shares of the company have lost 13.8% so far this year against the industry’s 1.1% growth.

MMSI’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 12.92%. In the last reported quarter, it delivered an earnings surprise of 17.44%.

Estimates for West Pharmaceutical’s 2025 earnings per share have increased 1.2% to $6.74 in the past 60 days. Shares of the company have lost 18.2% so far this year against the industry’s 1% growth.

WST’s earnings beat estimates in each of the trailing four quarters, the average surprise being 16.81%. In the last reported quarter, it delivered an earnings surprise of 21.85%.

-

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Vera Bradley, Inc. (NASDAQ: VRA) resulting from allegations that Vera Bradley may have issued materially misleading business information to the investing public.

So What: If you purchased Vera Bradley securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

What to do next: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=40454 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

What is this about: On June 11, 2025, Vera Bradley announced its financial results for the first quarter of the 2026 fiscal year. Commenting on the results, Vera Bradley’s CEO stated that “[o]ur first quarter results were disappointing as top line and profitability trends from the previous several quarters continued.”

On this news, the price of Vera Bradley stock fell 19% on June 11, 2025.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

More News From The Rosen Law Firm, P.A.

Back to Newsroom

PHOENIX & NEW YORK--(BUSINESS WIRE)--The Blackstone Charitable Foundation has awarded a $3 million grant to launch Blackstone Skilled Futures in partnership with Arizona State University, Maricopa Community Colleges and local nonprofits. The program aims to increase access to high-quality training and workforce development, focusing on construction and advanced manufacturing in the Phoenix area. Blackstone Skilled Futures will support students in need, along with capacity building for training.

Key Takeaways Commercial Metals posted Q4 EPS of $1.37, topping estimates and rising from 84 cents last year.Q4 net sales climbed 5.9% year over year to $2.11B, driven by strength across all operating segments.CMC agreed to buy Foley Products for $1.84B, expanding into precast applications and boosting market reach.
Commercial Metals Company (CMC - Free Report) reported earnings per share (EPS) of $1.35 for the fourth quarter of fiscal 2025 (ended Aug. 31, 2025) compared with 90 cents in the year-ago quarter. Adjusted for one-time items, the earnings came in at $1.37. The bottom line beat the Zacks Consensus Estimate of $1.32.

Net sales in the reported quarter were around $2.11 billion, up 5.9% year over year. The reported figure beat the Zacks Consensus Estimate of $2.04 billion.

The cost of goods sold in the quarter was up 2.9% from the year-ago quarter to $1.72 billion. The gross profit was up 21.6% from the year-ago quarter to $393 million during this period. The core EBITDA was $291 million in the fiscal fourth quarter, up 32.9% from the year-ago quarter.

Commercial Metals’ Q4 Segment PerformancesThe North America Steel Group segment generated net sales of $1.62 billion in the fiscal fourth quarter compared with $1.56 billion in the year-ago quarter. We expected net sales of $1.61 billion for the quarter. The segment registered an adjusted EBITDA of $239 million compared with the year-ago quarter’s $203 million. Our model predicted an adjusted EBITDA of $228 million.

The Europe Steel Group segment’s revenues were $263 million, up 18.5% from the year-ago quarter. Our model predicted net sales of $227 million. The adjusted EBITDA was $39 million in the fiscal fourth quarter against the year-ago quarter’s negative $3.6 million. We expected an adjusted EBITDA of $5.2 million for the quarter.

The Emerging Businesses Group segment generated net sales of $222 million in the fiscal fourth quarter compared with $195.5 million in the year-ago quarter. We expected net sales of $169 million for the quarter. The segment registered an adjusted EBITDA of $50.6 million, up 19.1% year over year. Our model predicted an adjusted EBITDA of $58 million.

CMC’s FY25 PerformanceCommercial Metals reported adjusted earnings per share of $3.13 for fiscal 2025, marking a 24% decline from $4.13 in fiscal 2024. The bottom line beat the Zacks Consensus Estimate of $3.09. 

Revenues dropped 1.6% year over year to $7.79 billion in fiscal 2025, beating the Zacks Consensus Estimate of $7.75 billion.

Commercial Metals’ Q4 Cash Flow & Balance Sheet UpdatesCMC reported cash and cash equivalents of $1.04 billion at the end of fiscal 2025 compared with $0.86 billion at the end of fiscal 2024. The company’s long-term debt was $1.31 billion at the end of fiscal 2025 compared with $1.15 billion at the end of fiscal 2024. Cash generated from operating activities was $715 million in fiscal 2025 compared with $899.7 million in the last fiscal year.

CMC’s Other UpdatesThe company announced on Thursday that it has inked a definitive agreement to acquire Foley Products Company for $1.84 billion in cash. Along with the pending CP&P acquisition, this deal will expand the company’s commercial portfolio into mission-critical precast applications. It will establish CMC as the third-largest player in the United States, with a significant presence in the Mid-Atlantic and Southeast regions.

CMC expects the deal to be immediately accretive to EPS and free cash flow per share. By the end of year three, annual run-rate synergies are expected to be between $25 million and $30 million of EBITDA.

In mid-September, CMC announced that it had inked a definitive agreement with Eagle Corporation and ECPP, LLC to acquire Concrete Pipe & Precast, LLC ("CP&P"). This move will help Commercial Metals expand its early-stage construction solutions portfolio.

The deal is projected to be immediately accretive to CMC’s EPS and free cash flow per share. By the third year of completion, annual run-rate synergies from the transaction are expected to be between $5 million and $10 million, primarily related to optimization initiatives.

Commercial Metals’ FY26 OutlookThe company expects finished steel shipments within the North America Steel Group to follow normal seasonal trends in the first fiscal quarter of 2026. The adjusted EBITDA margin of the segment will rise sequentially, driven by higher steel product margins over scrap.

In the Emerging Businesses Group, results are expected to be down sequentially due to seasonality but increase on a year-over-year basis. Meanwhile, Europe Steel Group’s adjusted EBITDA is likely to remain near breakeven. Overall, financial results in the first quarter of fiscal 2026 are expected to be in line with the fourth quarter results.

CMC’s Share Price Outperforms IndustryShares of the company have lost 0.5% in the past year against the industry’s growth of 5.5%.

Image Source: Zacks Investment Research

Commercial Metals’ Zacks RankCommercial Metals currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Steel-Producers Stocks Awaiting ResultsL.B. Foster Company (FSTR - Free Report) is expected to release its third-quarter 2025 results soon.

The Zacks Consensus Estimate for FSTR’s EPS is pegged at 61 cents for the third quarter, suggesting growth from the 54 cents reported in the year-ago quarter. For total revenues, the Zacks Consensus Estimate is pinned at $153.6 million, indicating a year-over-year increase of 11.7%.

Gerdau S.A. (GGB - Free Report) is expected to release third-quarter 2025 results on Oct. 30.

The Zacks Consensus Estimate for GGB’s EPS is pegged at 12 cents for the third quarter, suggesting a dip of 7.7% from the year-ago reported figure. For total revenues, the Zacks Consensus Estimate is pinned at $3.2 billion, indicating a year-over-year increase of 4%.

Ternium S.A. (TX - Free Report) is expected to release third-quarter 2025 results soon.

The Zacks Consensus Estimate for TX’s EPS is pegged at 81 cents for the fiscal third quarter, suggesting a rise from 16 cents reported in the year-ago period. For total revenues, the Zacks Consensus Estimate is pinned at $3.99 billion, indicating a year-over-year decrease of 10.7%.